WCM Investment Management LLC Has $922.28 Million Stock Holdings in STERIS plc (NYSE:STE)

WCM Investment Management LLC lessened its holdings in STERIS plc (NYSE:STEFree Report) by 3.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 4,497,191 shares of the medical equipment provider’s stock after selling 183,346 shares during the quarter. STERIS comprises approximately 2.2% of WCM Investment Management LLC’s portfolio, making the stock its 16th largest holding. WCM Investment Management LLC’s holdings in STERIS were worth $922,284,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Ashton Thomas Securities LLC acquired a new position in STERIS in the third quarter worth about $25,000. Central Pacific Bank Trust Division increased its holdings in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares in the last quarter. Quarry LP acquired a new stake in shares of STERIS during the third quarter worth approximately $67,000. Asset Dedication LLC increased its holdings in shares of STERIS by 54.8% during the third quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock worth $71,000 after buying an additional 103 shares in the last quarter. Finally, R Squared Ltd acquired a new stake in shares of STERIS during the fourth quarter worth approximately $78,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $217.32, for a total value of $365,532.24. Following the transaction, the senior vice president now directly owns 11,372 shares of the company’s stock, valued at $2,471,363.04. This represents a 12.88 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on STE. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, November 8th. Stephens reissued an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday. StockNews.com lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday. Finally, Piper Sandler raised their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $258.75.

View Our Latest Report on STERIS

STERIS Trading Down 1.0 %

Shares of NYSE:STE opened at $223.13 on Friday. The company’s 50-day moving average price is $212.57 and its two-hundred day moving average price is $224.56. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.55. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The stock has a market capitalization of $22.03 billion, a PE ratio of 47.37 and a beta of 0.84.

STERIS (NYSE:STEGet Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.02%. STERIS’s dividend payout ratio is currently 48.41%.

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Read More

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.